Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)
Phase 4
Terminated
- Conditions
- HivNeurocognitive Dysfunction
- Interventions
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 38
- Registration Number
- NCT03163277
- Locations
- ๐ฎ๐น
University of Torino, Torino, Italy
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Phase 4
Terminated
- Conditions
- HIV InfectionOsteopenia
- Interventions
- Drug: tenofovir/emtricitabine and atazanavir and ritonavir
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 4
- Registration Number
- NCT01902186
- Locations
- ๐ฎ๐น
University of Milano, Milano, Italy
๐ฎ๐นUniversity of Torino, Torino, Italy
Early- and Late-onset Candidemia
Completed
- Conditions
- Candidemia
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 400
- Registration Number
- NCT01406093
- Locations
- ๐ฎ๐น
Hospital San Giovanni Battista - Molinette, Torino, Italy
ยฉ Copyright 2025. All Rights Reserved by MedPath